First in Human Dosed in Clinical Trial of ZMA001 for Treatment of Pulmonary Arterial Hypertension (PAH)
INCHEON, South Korea, Feb. 8, 2024 /PRNewswire/ -- Zymedi announced today that the first in human dosage of ZMA001, a monoclonal antibody being developed as a first-in-class treatment for Pulmonary Arterial Hypertension (PAH) has been initiated. The...
New SANOIN Study Findings show Significant Rise in Hb levels in 14 days, Symptom Relief in 30 days & Improved Quality of life in women with Iron Deficiency Anemia
SANOIN clinical study supported by P&G Health demonstrates efficacy of iron supplementation (ferrous gluconate + multivitamin & minerals) in improving Hb levels & Quality of life with demonstrated symptom relief With 1 in 4 people...
Global Times: Spring Festival links tradition, promotes global values
BEIJING, Feb. 8, 2024 /PRNewswire/ -- Chinese President Xi Jinping highly values culture and has a profound understanding of culture which has strengthened over time. Culture plays a vital role in inspiring national spirit, carrying forward...
RoboForex Introduces the Infinity Program: Revolutionising Partnership and Affiliate Marketing in Financial Trading
BELIZE CITY, Belize, Feb. 8, 2024 /PRNewswire/ -- RoboForex, a company that offers brokerage services in financial markets, announced the launch of its innovative Infinity Program, marking a significant evolution of its existing Partner Programs....
BeyonCa Founder Soh Urges Creation of New Automotive Ecosystem Amid Fragmentation of Supply Chain and AI-driven Transformation
BEIJING, Feb. 8, 2024 /PRNewswire/ -- During a recent investment roundtable with Barron's China, Singaporean Weiming Soh, a seasoned figure in the automotive industry and the founder-chairman of the premium smart EV company BeyonCa, advocated the...
i-Battery CEO Feng Yong: bullish on vanadium batteries' future in Japan
SUZHOU, China and TOKYO, Feb. 8, 2024 /PRNewswire/ -- i-Battery Energy Technology (Suzhou) Co., Ltd ("i-Battery")'s CEO, Feng Yong, in a special interview with Japanese media ENERGYBIZ, discussed the promising future deployment of i-Battery's...
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
MELBOURNE, Australia , Feb. 8, 2024 /PRNewswire/ --.Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences, Inc. (U.S. OTC: QSAM) and its lead investigational drug...
Stena RoRo takes delivery of E-Flexer RoPax vessel number ten for long charter to Canadian Crown Corporation Marine Atlantic
GOTHENBURG, Sweden, Feb. 8, 2024 /PRNewswire/ -- Today, number ten of the Stena RoRos E-Flexer series was delivered from the CMI Jinling, Weihai Shipyard. The vessel, named Ala'suinu, will be on a long charter agreement with the Canadian state-owned...